Volume 29, Number 4—April 2023
Research Letter
Retrospective Screening of Clinical Samples for Monkeypox Virus DNA, California, USA, 2022
Figure

Figure. Flowchart of retrospective quantitative PCR screening for MPXV in oropharyngeal and rectal swab samples submitted for Chlamydia trachomatis and Neisseria gonorrhoeae testing, California, USA, 2022. Patients with known MPXV infection (n = 12) were diagnosed by quantitative PCR of cutaneous lesions. Patients without known mpox did not have MPXV-positive tests or cutaneous lesions at the time of specimen collection for C. trachomatis and N. gonorrhoeae testing. MPXV, monkeypox virus.
Page created: February 13, 2023
Page updated: March 21, 2023
Page reviewed: March 21, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.